API Gallery
The global Raltitrexed market is projected to grow at a CAGR of 6.3% during the forecast period 2025-2035. This growth is driven by its expanding role in oncology, particularly for the treatment of advanced colorectal and gastric cancers.
Stevioside A3market is experiencing a CAGR of 7.5% during the forecast period. The increasing demand for natural, zero-calorie sweeteners in health-conscious consumer segments and the growing pharmaceutical applications for managing blood glucose levels are key drivers.
The global Ramelteon market is projected to grow at a CAGR of 7.2% during the forecast period, driven by its increasing use as a non-habit-forming treatment for sleep-onset insomnia and circadian rhythm disorders.
The global Ramipril market is projected to grow at a CAGR of 5.2% during the forecast period, driven by its established role in the treatment of hypertension, heart failure, and post-myocardial infarction care.
The global Ramucirumab market is projected to grow at a CAGR of 6.4% during the forecast period 2025-2035, driven by its expanding use in the treatment of various advanced cancers, including gastric, colorectal, and non-small cell lung cancers.
The global Ranibizumab market is projected to grow at a CAGR of 4.3% during the forecast period, driven by its established role in the treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic retinopathy, and macular edema.
Streptomycin market is experiencing a CAGR of 5.6% during the forecast period, driven by its critical role as a broad-spectrum antibiotic for treating tuberculosis and other bacterial infections.
Streptozotocin market is experiencing a CAGR of 6.2% during the forecast period, driven by rising incidences of pancreatic cancer and growing research on diabetes and β-cell cytotoxicity.
Sufentanil market is experiencing a CAGR of 6.4% during the forecast period.
Sufentanil citrate market is experiencing a CAGR of 6.4% during the forecast period.
Sodium Methylparaben API market is experiencing a CAGR of 5.9% during the forecast period.
Sodium Nitrate API market is experiencing a CAGR of 5.9% during the forecast period.
Sodium Oxybate API market is experiencing a CAGR of 8.5% during the forecast period, This growth is primarily driven by rising awareness of narcolepsy and other sleep disorders, alongside increasing prescriptions for sodium oxybate-based therapeutics such as Xyrem and Xywav.
Sodium Phenylbutyrate market is experiencing a CAGR of 10.3 % during the forecast period, This growth is driven by the increasing prevalence of urea cycle disorders (UCDs) and other rare metabolic diseases, where sodium phenylbutyrate plays a critical therapeutic role.
Sodium Selenite API market is experiencing a CAGR of 7.7% during the forecast period, Sodium selenite, a key source of selenium, is increasingly used as an active pharmaceutical ingredient (API) in the treatment of selenium deficiency, cancer support therapies, and as a nutritional supplement in both human and veterinary medicine.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
